Melatonina
Anno: 1995
-
Riferimento:Carcinogenesis. 1995 Dec;16(12):2945-9.Azione della melatonina:Oncostatic action of melatonin[10(-10) M]is exerted through modulation of the levels of gap junctional intercellular communication. Also, the data indicate that ELF-MF could counteract the melatonin-induced enhancement of junctional transfer.Target:Extremely low frequency (ELF magnetic fields(MF)
-
Titolo: Melatoni blocks the stimulatory effects of prolactin on human breast cancer cell growth in cultureRiferimento:Br J Cancer. 1995 Dec;72(6):1435-40.Azione della melatonina:Mlt interrupts the PRL receptor (PRLR)-mediated growth signal in HBC and suggest that the oncostatic activity of Mlt may also be linked with an antagonism of PRL's actions.Target:Monoclonal antibodies (Mabs) against PRLR
-
Riferimento:Oncol Rep. 1995 Nov;2(6):1063-8.Azione della melatonina:Induce objective tumor regressions in most advanced solid tumor histotypes by low-dose IL-2 plus MLT (orally at 40 mg/day).Target:Interleukin-2 (IL.2)
-
Riferimento:Anticancer Res. 1995 Nov-Dec;15(6B):2633-7.Azione della melatonina:Patients with multiple myeloma showed significantly higher mean melatonin serum levels, increased secretion might be considered as a compensatory mechanism of regulating neoplastic growth.Target:Antineoplastic activity.
-
Titolo: The nuclear receptor for melatonin represses 5-lipoxygenase gene expression in human B lymphocytesRiferimento:J Biol Chem. 1995 Mar 31;270(13):7037-40.Azione della melatonina:Melatonin is a natural ligand of RZR alpha and RZR beta, down-regulating the expression of 5-lipoxygenase about 5-fold in B-Lymphocytes.Target:Retinoid Z receptor (RZR alpha and beta).
-
Riferimento:Oncol Rep. 1995 Sep;2(5):871-3.Azione della melatonina:Association of MLT(20 mg/day orally) may make TMX effective also in ER-negative metastatic breast cancer patients.Target:Tamoxifen (TMX) Melatonin(MLT) Estrogen receptor (ER)
-
Riferimento:Cancer Lett. 1995 Jul 13;93(2):207-12.Azione della melatonina:Direct relation between proliferative rate of cells and melatonin (10(-9)M) actions on MCF-7 cells.Target:Inhibitory actions on cell growth
-
Riferimento:Oncology. 1995 Jul-Aug;52(4):278-83.Azione della melatonina:Clear stimulation of the immune system and Mlt at early but inhibition at advanced stages of cancer.Target:Mlt and cellular immunity
Anno: 1996
-
Riferimento:J Pineal Res. 1996 Apr;20(3):173.Azione della melatonina:No abstract available.Target:No abstract available.
-
Riferimento:J Toxicol Environ Health. 1996 Jun 7;48(2):169-85.Azione della melatonina:50-Hz, 100-mG MF significantly decreases circulating melatonin but is not associated with a development of DMBA-induced mammary tumors.Target:Dimethylbenzanthracene (DMBA) Magnetic field (MF)